[SCHEDULE 13G/A] CF Industries Holding, Inc. SEC Filing
Filing: Schedule 13G/A by FMR LLC and Abigail P. Johnson reporting holdings in CF Industries Holdings, Inc. (CUSIP 125269100).
As of 06/30/2025 the reporting persons beneficially own 5,301,002.74 shares, representing 3.3% of the outstanding common stock. FMR LLC reports 3,822,093.76 shares of sole voting power and 5,301,002.74 shares of sole dispositive power. Abigail P. Johnson reports sole dispositive power for the same 5,301,002.74 shares. The filing is signed 08/05/2025 and includes a certification that the holdings are held in the ordinary course of business.
Deposito: Schedule 13G/A presentato da FMR LLC e Abigail P. Johnson che segnala partecipazioni in CF Industries Holdings, Inc. (CUSIP 125269100).
Alla data del 30/06/2025 le persone segnalanti detengono beneficiariamente 5.301.002,74 azioni, pari al 3,3% del capitale sociale in circolazione. FMR LLC dichiara 3.822.093,76 azioni con potere di voto esclusivo e 5.301.002,74 azioni con potere dispositivo esclusivo. Abigail P. Johnson dichiara il potere dispositvo esclusivo sulle stesse 5.301.002,74 azioni. Il deposito 猫 firmato il 05/08/2025 e include una certificazione che le partecipazioni sono detenute nell'ordinaria gestione dell'attivit脿 aziendale.
笔谤别蝉别苍迟补肠颈贸苍: Schedule 13G/A presentado por FMR LLC y Abigail P. Johnson informando participaciones en CF Industries Holdings, Inc. (CUSIP 125269100).
Al 30/06/2025 las personas informantes poseen beneficiariamente 5.301.002,74 acciones, que representan el 3,3% del capital social en circulaci贸n. FMR LLC declara 3.822.093,76 acciones con poder de voto exclusivo y 5.301.002,74 acciones con poder dispositivo exclusivo. Abigail P. Johnson declara el poder dispositvo exclusivo sobre las mismas 5.301.002,74 acciones. La presentaci贸n est谩 firmada el 05/08/2025 e incluye una certificaci贸n de que las participaciones se mantienen en el curso ordinario del negocio.
鞝涤稖: CF Industries Holdings, Inc. (CUSIP 125269100)鞐� 雽�頃� 氤挫湢毳� 鞁犼碃頃橂姅 FMR LLC 氚� Abigail P. Johnson鞚� Schedule 13G/A.
2025雲� 6鞗� 30鞚� 旮办鞙茧 鞁犼碃鞚胳潃 靾橃澋鞝侅溂搿� 5,301,002.74欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 鞙犿喌 氤错喌欤� 齑濎垬鞚� 3.3%鞐� 頃措嫻頃╇媹雼�. FMR LLC電� 雼弲 鞚橁舶甓岇潉 臧�歆� 3,822,093.76欤检檧 雼弲 觳橂秳甓岇潉 臧�歆� 5,301,002.74欤茧ゼ 鞁犼碃頄堨姷雼堧嫟. Abigail P. Johnson鞚� 霃欖澕頃� 5,301,002.74欤检棎 雽�頃� 雼弲 觳橂秳甓岇潉 鞁犼碃頄堨姷雼堧嫟. 氤� 鞝滌稖靹滊姅 2025雲� 8鞗� 5鞚�鞐� 靹滊獏霅橃棃鞙茧┌, 氤挫湢 欤检嫕鞚� 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堧嫟電� 鞚胳鞚� 韽暔頃╇媹雼�.
D茅p么t : Schedule 13G/A d茅pos茅 par FMR LLC et Abigail P. Johnson signalant des participations dans CF Industries Holdings, Inc. (CUSIP 125269100).
Au 30/06/2025, les personnes d茅clarante d茅tiennent 脿 titre b茅n茅ficiaire 5 301 002,74 actions, repr茅sentant 3,3 % du capital social en circulation. FMR LLC d茅clare 3 822 093,76 actions avec pouvoir de vote exclusif et 5 301 002,74 actions avec pouvoir de disposition exclusif. Abigail P. Johnson d茅clare le pouvoir de disposition exclusif pour ces m锚mes 5 301 002,74 actions. Le d茅p么t est sign茅 le 05/08/2025 et comprend une certification attestant que les participations sont d茅tenues dans le cours normal de l'activit茅.
Einreichung: Schedule 13G/A von FMR LLC und Abigail P. Johnson zur Meldung von Beteiligungen an CF Industries Holdings, Inc. (CUSIP 125269100).
Zum 30.06.2025 besitzen die meldenden Personen wirtschaftlich 5.301.002,74 Aktien, was 3,3% des ausstehenden Stammkapitals entspricht. FMR LLC meldet 3.822.093,76 Aktien mit alleinigem Stimmrecht und 5.301.002,74 Aktien mit alleinigem Verf眉gungsrecht. Abigail P. Johnson meldet das alleinige Verf眉gungsrecht f眉r dieselben 5.301.002,74 Aktien. Die Einreichung ist am 05.08.2025 unterzeichnet und enth盲lt eine Best盲tigung, dass die Beteiligungen im gew枚hnlichen Gesch盲ftsbetrieb gehalten werden.
- None.
- None.
Insights
TL;DR: Routine passive ownership disclosure: FMR LLC/Abigail P. Johnson report a 3.3% stake (5.301M shares) in CF Industries.
The Schedule 13G/A documents beneficial ownership totaling 5,301,002.74 shares (3.3%) as of 06/30/2025. FMR LLC reports sole voting power of 3,822,093.76 shares and sole dispositive power equal to the aggregate holdings. No shared voting or dispositive power is reported. The disclosure is consistent with a passive, ordinary-course position and falls below the 5% threshold that typically triggers more active reporting obligations.
TL;DR: Filing affirms ordinary-course holdings and no intent to influence issuer control per Item 10 certification.
The statement includes the Item 10 certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Reporting-person classifications appear as HC for FMR LLC and IN for Abigail P. Johnson on the cover. The filing references a power of attorney exhibit for signature authority and is dated 08/05/2025.
Deposito: Schedule 13G/A presentato da FMR LLC e Abigail P. Johnson che segnala partecipazioni in CF Industries Holdings, Inc. (CUSIP 125269100).
Alla data del 30/06/2025 le persone segnalanti detengono beneficiariamente 5.301.002,74 azioni, pari al 3,3% del capitale sociale in circolazione. FMR LLC dichiara 3.822.093,76 azioni con potere di voto esclusivo e 5.301.002,74 azioni con potere dispositivo esclusivo. Abigail P. Johnson dichiara il potere dispositvo esclusivo sulle stesse 5.301.002,74 azioni. Il deposito 猫 firmato il 05/08/2025 e include una certificazione che le partecipazioni sono detenute nell'ordinaria gestione dell'attivit脿 aziendale.
笔谤别蝉别苍迟补肠颈贸苍: Schedule 13G/A presentado por FMR LLC y Abigail P. Johnson informando participaciones en CF Industries Holdings, Inc. (CUSIP 125269100).
Al 30/06/2025 las personas informantes poseen beneficiariamente 5.301.002,74 acciones, que representan el 3,3% del capital social en circulaci贸n. FMR LLC declara 3.822.093,76 acciones con poder de voto exclusivo y 5.301.002,74 acciones con poder dispositivo exclusivo. Abigail P. Johnson declara el poder dispositvo exclusivo sobre las mismas 5.301.002,74 acciones. La presentaci贸n est谩 firmada el 05/08/2025 e incluye una certificaci贸n de que las participaciones se mantienen en el curso ordinario del negocio.
鞝涤稖: CF Industries Holdings, Inc. (CUSIP 125269100)鞐� 雽�頃� 氤挫湢毳� 鞁犼碃頃橂姅 FMR LLC 氚� Abigail P. Johnson鞚� Schedule 13G/A.
2025雲� 6鞗� 30鞚� 旮办鞙茧 鞁犼碃鞚胳潃 靾橃澋鞝侅溂搿� 5,301,002.74欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 鞙犿喌 氤错喌欤� 齑濎垬鞚� 3.3%鞐� 頃措嫻頃╇媹雼�. FMR LLC電� 雼弲 鞚橁舶甓岇潉 臧�歆� 3,822,093.76欤检檧 雼弲 觳橂秳甓岇潉 臧�歆� 5,301,002.74欤茧ゼ 鞁犼碃頄堨姷雼堧嫟. Abigail P. Johnson鞚� 霃欖澕頃� 5,301,002.74欤检棎 雽�頃� 雼弲 觳橂秳甓岇潉 鞁犼碃頄堨姷雼堧嫟. 氤� 鞝滌稖靹滊姅 2025雲� 8鞗� 5鞚�鞐� 靹滊獏霅橃棃鞙茧┌, 氤挫湢 欤检嫕鞚� 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅橁碃 鞛堧嫟電� 鞚胳鞚� 韽暔頃╇媹雼�.
D茅p么t : Schedule 13G/A d茅pos茅 par FMR LLC et Abigail P. Johnson signalant des participations dans CF Industries Holdings, Inc. (CUSIP 125269100).
Au 30/06/2025, les personnes d茅clarante d茅tiennent 脿 titre b茅n茅ficiaire 5 301 002,74 actions, repr茅sentant 3,3 % du capital social en circulation. FMR LLC d茅clare 3 822 093,76 actions avec pouvoir de vote exclusif et 5 301 002,74 actions avec pouvoir de disposition exclusif. Abigail P. Johnson d茅clare le pouvoir de disposition exclusif pour ces m锚mes 5 301 002,74 actions. Le d茅p么t est sign茅 le 05/08/2025 et comprend une certification attestant que les participations sont d茅tenues dans le cours normal de l'activit茅.
Einreichung: Schedule 13G/A von FMR LLC und Abigail P. Johnson zur Meldung von Beteiligungen an CF Industries Holdings, Inc. (CUSIP 125269100).
Zum 30.06.2025 besitzen die meldenden Personen wirtschaftlich 5.301.002,74 Aktien, was 3,3% des ausstehenden Stammkapitals entspricht. FMR LLC meldet 3.822.093,76 Aktien mit alleinigem Stimmrecht und 5.301.002,74 Aktien mit alleinigem Verf眉gungsrecht. Abigail P. Johnson meldet das alleinige Verf眉gungsrecht f眉r dieselben 5.301.002,74 Aktien. Die Einreichung ist am 05.08.2025 unterzeichnet und enth盲lt eine Best盲tigung, dass die Beteiligungen im gew枚hnlichen Gesch盲ftsbetrieb gehalten werden.
FAQ
What stake did FMR LLC report in CF Industries (CF)?
What voting and dispositive power does FMR LLC report?
Who are the reporting persons on this Schedule 13G/A?
What are the relevant dates in the filing?
Does the filing state an intent to influence control of CF Industries?
What is the issuer and CUSIP referenced in the filing?
